טוען...
USP22 upregulates ZEB1-mediated VEGFA transcription in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a common solid tumor with high rate of recurrence and mortality. Anti-angiogenesis drugs have been used for the therapy of HCC. However, anti-angiogenic drug resistance commonly occurs during HCC treatment. Thus, identification of a novel VEGFA regulator would be be...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
פורמט: | Online Artículo Texto |
שפה: | English |
יצא לאור: |
Nature Publishing Group UK
2023
|
נושאים: | |
גישה מקוונת: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008583/ https://www.ncbi.nlm.nih.gov/pubmed/36906615 http://dx.doi.org/10.1038/s41419-023-05699-y |